{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T14:24:31Z","timestamp":1781360671548,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015758","name":"Novo Nordisk Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015758","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ghir.2017.08.005","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T09:31:22Z","timestamp":1504258282000},"page":"36-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Assessment of quality of life on 4-year growth hormone therapy in Japanese patients with adult growth hormone deficiency: A post-marketing, multicenter, observational study"],"prefix":"10.1016","volume":"36","author":[{"given":"Hitoshi","family":"Ishii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Nishinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Chihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2017.08.005_bb0005","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ghir.2008.02.002","article-title":"Efficacy and safety of individualized growth hormone treatment in adult Japanese patients with growth hormone deficiency","volume":"18","author":"Chihara","year":"2008","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2017.08.005_bb0010","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1186\/1756-0500-7-813","article-title":"Impact of adult growth hormone deficiency on daily functioning and well-being","volume":"7","author":"Brod","year":"2014","journal-title":"BMC. Res. Notes"},{"key":"10.1016\/j.ghir.2017.08.005_bb0015","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1210\/jc.2013-3438","article-title":"Assessing the impact of growth hormone deficiency and treatment in adults: development of a new disease-specific measure","volume":"99","author":"Brod","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.08.005_bb0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1008987922774","article-title":"The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency","volume":"8","author":"McKenna","year":"1999","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.ghir.2017.08.005_bb0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/eje.0.1450255","article-title":"Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency","volume":"145","author":"Herschbach","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2017.08.005_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ghir.2010.10.005","article-title":"The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database","volume":"21","author":"Spielhagen","year":"2011","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2017.08.005_bb0035","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1210\/jc.2003-030134","article-title":"Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H)","volume":"89","author":"Rosilio","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.08.005_bb0040","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1210\/jc.2002-021792","article-title":"Decreased quality of life in adult patients with growth hormone deficiency compared with general populations using the new, validated, self-weighted questionnaire, questions on life satisfaction hypopituitarism module","volume":"88","author":"Blum","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.08.005_bb0045","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1210\/jc.2014-2892","article-title":"Ten-year change in quality of life in adults on growth hormone replacement for growth hormone deficiency: an analysis of the hypopituitary control and complications study","volume":"99","author":"Mo","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.08.005_bb0050","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2265.1999.00722.x","article-title":"Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults","volume":"50","author":"Murray","year":"1999","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2017.08.005_bb0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ghir.2006.03.012","article-title":"Efficacy and safety of growth hormone (GH) in the treatment of adult Japanese patients with GH deficiency: a randomised, placebo-controlled study","volume":"16","author":"Chihara","year":"2006","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2017.08.005_bb0060","series-title":"Pharmaceuticals and Medical Devices Agency (PMDA): Genotropin Assessment Report","year":"2017"},{"key":"10.1016\/j.ghir.2017.08.005_bb0065","first-page":"1905","article-title":"The \u201cquality of life-assessment of growth hormone deficiency in adults\u201d questionnaire: can it be used to assess quality of life in hypopituitarism?","volume":"86","author":"Barkan","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.08.005_bb0070","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ghir.2006.09.002","article-title":"Validation of the Japanese version of the quality of life-assessment of growth hormone deficiency in adults (QoL-AGHDA)","volume":"16","author":"Suzukamo","year":"2006","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2017.08.005_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044304","article-title":"Development and validation of a new questionnaire assessing quality of life in adults with hypopituitarism: adult hypopituitarism questionnaire (AHQ)","volume":"7","author":"Ishii","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ghir.2017.08.005_bb0080","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1530\/EJE-11-0657","article-title":"GH deficiency in patients after cure of acromegaly by surgery alone","volume":"165","author":"Yamada","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2017.08.005_bb0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF03401402","article-title":"Long-term follow-up results of growth hormone therapy for patients with adult growth hormone deficiency","volume":"15","author":"Ikeda","year":"2016","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.ghir.2017.08.005_bb0090","series-title":"Norditropin\u00ae Patient Information and Instructions for Use","year":"2017"},{"key":"10.1016\/j.ghir.2017.08.005_bb0095","series-title":"The Diagnosis and Treatment of Adult Growth Hormone Deficiency in Japan by the Task Force for Hypothalamo-Hypophysial Dysfunction","year":"2014"},{"key":"10.1016\/j.ghir.2017.08.005_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1530\/EJE-07-0066","article-title":"A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency","volume":"157","author":"Chihara","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2017.08.005_bb0105","series-title":"Japanese package insert. Revised June 2017 (3rd version)","article-title":"Norditropin\u00ae FlexPro\u00ae 5mg, 10mg, 15mg for injection human growth hormone (genetical recombination) preparation","year":"2017"},{"key":"10.1016\/j.ghir.2017.08.005_bb0110","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1210\/jc.2012-2901","article-title":"IGF-I bioactivity might reflect different aspects of quality of life than total IGF-I in GH-deficient patients during GH treatment","volume":"98","author":"Varewijck","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.08.005_bb0115","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1210\/jcem.84.11.6088","article-title":"The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board","volume":"84","author":"Bengtsson","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.08.005_bb0120","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.08.005_bb0125","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2265.1993.tb02411.x","article-title":"Effects of oestrogen status on serum levels of growth hormone-binding protein and insulin-like growth factor-I in non-pregnant and pregnant women","volume":"39","author":"Massa","year":"1993","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2017.08.005_bb0130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2265.1993.tb02410.x","article-title":"Effects of differential oral oestrogen formulations on insulin-like growth factor, growth hormone and growth hormone binding protein in postmenopausal women","volume":"39","author":"Kelly","year":"1993","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2017.08.005_bb0135","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/jbmr.5650091108","article-title":"Interactions of growth hormone and parathyroid hormone in renal phosphate, calcium and calcitriol metabolism and bone remodeling in postmenopausal women","volume":"9","author":"Liberman","year":"1994","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ghir.2017.08.005_bb0140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ghir.2003.12.001","article-title":"Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption","volume":"14","author":"Svensson","year":"2004","journal-title":"Growth Hormon. IGF Res."}],"updated-by":[{"DOI":"10.1016\/j.ghir.2018.02.003","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000}}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637417300734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637417300734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T00:54:45Z","timestamp":1657414485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637417300734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":28,"alternative-id":["S1096637417300734"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2017.08.005","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ghir.2018.02.003","asserted-by":"object"}]},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of quality of life on 4-year growth hormone therapy in Japanese patients with adult growth hormone deficiency: A post-marketing, multicenter, observational study","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2017.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}